000 | 01041nam a22003497a 4500 | ||
---|---|---|---|
008 | 130708b xxu||||| |||| 00| 0 eng d | ||
020 | _a978 90 382 2172 4 | ||
040 | _cVAD | ||
041 | _aEngels | ||
100 | _aVander Laenen, Freya | ||
245 | _aAnalysis and optimization of substitution treatment in Belgium (SUBANOP) [PDF] | ||
260 |
_aGent _bAcademia Press _c2013 |
||
300 | _aXIV, 210 p. | ||
490 | _aScience and society | ||
650 | _adrugs | ||
650 | _aheroïne | ||
650 | _amethadon | ||
650 | _abuprenorfine | ||
650 | _ahulpverlening | ||
650 | _afarmacotherapie | ||
650 | _aBelgië | ||
650 | _aonderzoeksrapporten | ||
650 | _autilization studies | ||
700 | _aVanderplasschen, Wouter | ||
700 | _aSmet, Valérie | ||
700 | _aDe Maeyer, Jessica | ||
700 | _aBuckinx, Margaux | ||
700 | _aVan Audenhove, Sharon | ||
700 | _aAnsseau, Marc | ||
700 | _aDe Ruyver, Brice | ||
856 | _uhttp://www.google.com/search?q=Analysis-and-optimization-of-substitution-treatment-in-Belgium belspo | ||
999 |
_c16941 _d16941 |